GEG Tech’s mission is to design safe and powerful innovations deriving from genetic engineering.
To accomplish this mission, we :
– Invest continuously in genetic engineering R&D, to expand our technology platform
– Design innovations exploiting our technology platform
– Partner with advanced labs and biotechs, to design breakthrough innovations
GEG proprietary platform is constantly enriched as our R&D delivers new tools, know-how and knowledge. GEG Tech has designed among other things a new generation of biological mRNA vectors that are far more precise, efficient, and safer than the currently available chemical or viral particles.
Early 2025, as we update this paragraph, GEG platform addresses the following areas:
– Cancer immunotherapy, CAR-T cells, mRNA therapeutic vaccination
– mRNA prophylactic vaccination against virus, bacteria or parasites
– Gene therapy applications leveraged by RNA/DNA vectorization systems
– Dermatology based on mRNA vectorization systems
– R&D tools (custom advanced RNA/DNA vectors)
GEG Tech has been founded in 2013 in Paris, France. Our R&D team originated from cutting-edge research laboratories, notably the CNRS (the leading French research institution), and the Riken Institute (Japan), cumulating more than 20 years’ experience in pioneering research on genetic engineering and vectorology.
GEG Tech laboratory is located near Paris, France, in the heart of Plateau de Saclay, in R&D center Spartners which benefits from state-of-the-art infrastructure and equipment.
